Showing results (261-270 of 536) with videos related to
Sort By:
Pageof 54
Diabetes, Obesity & Metabolism|June 20, 2024
A review of the latest real-world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions?Fabrice Bonnet, Mark E Cooper, Laetitia Kopp, et al.Plos Genetics|June 20, 2019
Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antiviralsShira Perez, Antony Kaspi, Tom Domovitz, et al.Journal of the American Society of Nephrology : JASN|July 23, 2003
Role of advanced glycation end products in diabetic nephropathyJosephine M Forbes, Mark E Cooper, Matthew D Oldfield, et al.Archives of Internal Medicine|March 2, 2005
Anemia with impaired erythropoietin response in diabetic patientsMerlin C Thomas, Mark E Cooper, Con Tsalamandris, et al.Journal of the American Society of Nephrology : JASN|December 25, 2003
Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritisVicki Levidiotis, Craig Freeman, Chris Tikellis, et al.Journal of Hypertension|April 22, 2009
Eplerenone does not attenuate diabetes-associated atherosclerosisPhilip J W Koh, Audrey Koitka, Mark E Cooper, et al.The Medical Journal of Australia|September 5, 2006
The assessment of kidney function by general practitioners in Australian patients with type 2 diabetes (NEFRON-2)Merlin C Thomas, Andrew J Weekes, Olivia J Broadley, et al.Genes|April 9, 2014
Role of Cell Division Autoantigen 1 (CDA1) in Cell Proliferation and FibrosisBan-Hock Toh, Yugang Tu, Zemin Cao, et al.The Journal of Clinical Investigation|January 12, 2023
Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetesIshant Khurana, Harikrishnan Kaipananickal, Scott Maxwell, et al.Nephrology (Carlton, Vic.)|May 10, 2005
Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody diseaseVicki Levidiotis, Craig Freeman, Chris Tikellis, et al.Pageof 54